Food and Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

January 13, 2003

 

 

The following people have enrolled to speak at the Open Public Hearing at today’s session:

 

 

Roscoe O. Brady, MD – National Institute of Neurological Disorders and Stroke

John A. Barranger, M.D., Ph.D. - University of Pittsburgh

Abbey S. Meyers - National Organization for Rare Disorders, Inc.

D.G. Warnock, MD – University of Alabama at Birmingham

Jean-Pierre Grünfeld M.D. - Université René Descartes, Paris, France

Jack Johnson – Fabry Support Information Group

Tracy Myatt – Clayton, North Carolina

Ricardo D. Borrego, M.D. - Grosse Pointe Park, Michigan

Haya (Jacqui) Howells - Allentown, Pennsylvania

Debra Johnson – Fabry Support Information Group

Gerald I. Walter – Springfield, Virginia

 

In addition, letters and e-mails were submitted from the public. Copies of these have been provided to the Committee and are available for public viewing in the two binders at the Information Desk. They will also be posted on the FDA website after the meeting and are considered part of the permanent meeting record.